🔎 Trials Near Me

Akèy › Kasinom Selil Skwamoz Ezofajyen › Texas › Houston

Etid klinik pou Kasinom Selil Skwamoz Ezofajyen nan Houston, TX

12 etid pou Kasinom Selil Skwamoz Ezofajyen ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Ap rekriteFaz 1
  • University of Texas MD Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07090499

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Ap rekriteFaz 1
  • ALX Center 5, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • MD Anderson, Houston
  • NEXT Oncology Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07217171

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05208762

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Oncology Consultants, PA, Houston
  • Oncology Consultants, PA., Houston
  • The University of Texas M.D. Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Study of XB010 in Subjects With Solid Tumors

Ap rekriteFaz 1
  • University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Ap rekriteFaz 1
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07503808

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Ap rekriteFaz 2
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Laj 18 ak plis · Tout sèks · Mizajou Nov 5, 2025 · NCT05563766

Etid Kasinom Selil Skwamoz Ezofajyen nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.